ערמוניה Израиль - иврит - Ministry of Health

ערמוניה

unipharm trading ltd, israel - dutasteride - קפסולות רכות - dutasteride 0.5 mg - dutasteride

ערמוניה Израиль - иврит - Ministry of Health

ערמוניה

unipharm trading ltd, israel - dutasteride - קפסולות רכות - dutasteride 0.5 mg - dutasteride

סלבוטק תמיסה לשאיפה Израиль - иврит - Ministry of Health

סלבוטק תמיסה לשאיפה

sam-on ltd - salbutamol as sulfate - תמיסה לשאיפה - salbutamol as sulfate 5 mg / 1 ml - salbutamol

פברזיים 35 מג Израиль - иврит - Ministry of Health

פברזיים 35 מג

sanofi israel ltd - agalsidase beta - אבקה להכנת תמיסה מרוכזת לעירוי - agalsidase beta 35 mg/vial - agalsidase beta - agalsidase beta - fabrazyme is indicated for use as long-term enzyme replacement therapy in patients with a confirmed diagnosis of fabry disease. (alfa - galactosidase a deficiency).

בטאפרון Израиль - иврит - Ministry of Health

בטאפרון

bayer israel ltd - interferon beta 1b - אבקה וממס להכנת תמיסה להזרקה - interferon beta 1b 0.3 mg/vial - interferon beta-1b - interferon beta-1b - use in ambulatory patients with relapsing-remitting multiple sclerosis (rrms) and relapsing progressive m.s. to reduce the frequency of clinical exacerbations. treatment of secondary progressive (sp) form of multiple sclerosis. treatment of patients who have experienced a single demyelinating event with an active inflammatory process, if it is severe enough to warrant treatment with intravenous corticosteroids, if alternative diagnoses have been excluded, including the prescence of mri abnormalities characteristic of m.s. and if they are determined to be at high risk of developing clinically definite multiple sclerosis.